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1 Introduction 
 
Over the last two decades, many studies have investigated the prenatal 
maternal exposure to different infectious agents and the offspring’s risk 
for mental disorders, mostly for schizophrenia. In the beginning, most of 
the studies used an ecologic study design, estimating the timing of the 
exposure to infectious agents retrospectively by obtaining data on 
epidemics in populations from different registries. Some studies also 
collected exposure data by interviewing the mothers during or shortly 
after pregnancy or using their medical records. Thereafter many studies 
requited a more accurate way of estimating maternal exposure, by 
investigating prospectively collected maternal sera. These studies have 
not focused on the mechanism by which the infectious agents increase 
the risk for mental disorders. To reveal the mechanisms and site of 
action of the infectious agents, researchers have used animal models.  
 
Several reviews of prenatal infectious agents as risk factors for different 
mental disorders in offspring exist so far. Most of these reviews have 
covered the effect of infectious agents and/or other prenatal exposures 
on the risk of schizophrenia. Some of them have chosen to focus on 
either human (1-3) or animal studies (4-7), whereas others have 
included both study designs (8-10). Two reviews have combined 
schizophrenia and autism as the main outcomes, one (11) including both 
human and animal studies and the other (12) focusing on 
epidemiological studies. One review (13) chose to focus on prenatal 
exposures and the risk of both schizophrenia and depression. Autism 
has been chosen to the subject of one review (14) including both human 
and animal studies. To the knowledge of the author, however, no 
reviews covering prenatal exposure to infectious agents and the risk of 
different mental disorders has been published. The aim of this review is 
to summarize the literature on prenatal maternal infection and immune 
response and explore their role in the development of schizophrenia 
spectrum disorders, autism spectrum disorders, and other mental and 
neurocognitive disorders.  
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2 Methods 
 
Studies were searched from PubMed database with the following 
keywords: Mental Disorders AND Prenatal Exposure Delayed Effects 
AND Infection AND Inflammation. All reviewed studies are described in 
the tables. 
 
 
3 Prenatal maternal infection and immune response and risk 
for mental disorders 
 
3.1 Schizophrenia Spectrum Disorders  
 
Human studies 
 
Of all mental disorders, clearly most attention has been paid to 
Schizophrenia Spectrum Disorders’ association with the exposure of 
prenatal maternal infection and immune response. A pioneer study by 
Mednick et al. was conducted in 1988 (15), using a Finnish birth cohort 
exposed to type A2 influenza epidemic in 1957. The authors found an 
association between second trimester exposure to influenza epidemic 
and increased risk for schizophrenia spectrum disorders. These results 
attracted attention of many researchers, and several replications of the 
results exist (16-17). Following studies have sought to overcome the 
methodological limitations of the study by requiting different study 
designs, as reviewed below. 
 
Support to the findings described below were derived from a study (16) in 
which the researchers sought to investigate the effect of prenatal 
exposure to maternal influenza on schizophrenia risk by retrospectively 
obtaining the data on influenza prevalence from a Danish national 
register. This study found that influenza exposure 4 months prior to birth 
was associated with an increased schizophrenia risk in the offspring (RR 
1.12, 95% CI 1.01-1.24). A French study (17) also found an association 
between exposure to maternal influenza and schizophrenia in the 
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offspring, as significantly more individuals with schizophrenia than 
controls had been exposed to the virus during the fifth month of 
pregnancy (individuals with schizophrenia: OR 2.24, 95% CI 1.49-3.35, 
controls: OR 1.61, 95% CI 1.04-2.49). The exposure to maternal 
influenza was estimated from the existence of national influenza 
epidemics. 
 
In contrast to these replications, also negative findings exist. One study 
(18) used a similar study design as the studies reviewed above, 
estimating the exposure from influenza epidemics, and no association 
was found between prenatal exposure to maternal influenza three, four 
or five months prior to the month of birth (RR 0.96, 95% CI 0.88-1.04; RR 
1.00, 95% CI 0.92-1.09; RR 1.01, 95% CI 0.93-1.10, respectively) and 
schizophrenia. 
 
In addition to examining the effect of prenatal exposure to maternal 
influenza on schizophrenia risk, the relationship between 16 different 
infectious diseases and risk of schizophrenia in the offspring was 
determined (19). Exposure was estimated by obtaining the data on the 
number of deaths from these diseases from a national registry, and the 
sample consisted of two independent sets of birth dates of patients with 
schizophrenia. In both of them, bronchopneumonia deaths preceded 
births of those with schizophrenia by three and five months. However, no 
association with the remaining 15 infectious diseases was found. 
 
The association between prenatal exposure to both maternal influenza 
and measles and risk of schizophrenia was studied in a study (20) in 
which the statewide exposure data was obtained from US statewide 
infectious disease tables. However, the retrospective study design did 
not able to determine whether the mother had actually been infected or 
not. Neither influenza nor measles exposure was found to be associated 
with schizophrenia risk in the offspring. 
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One group of researchers (21) took also seasonality into account, and 
sought to examine whether the prenatal exposure to maternal influenza 
is an independent risk factor for schizotypy, i.e. the presence of 
schizophrenic-like thought patterns in the absence of psychosis (22), or 
confounded with the effect of cold temperature. For this purpose, the 
study was conducted among Mauritian subjects, because Hong Kong 
influenza epidemic between 1968 and 1972 and cold temperature were 
not confounded in Mauritius. Schizotypy was measured by a two-factor 
scale, in which positive symptoms were labeled as schizophrenism (SZ) 
and negative symptoms as physical and social anhedonia (AH). Prenatal 
influenza exposure was found to be associated with elevated 
schizophrenism, whereas exposure to low temperatures was associated 
with elevated anhedonia in the offspring. 
 
One limitation of all of the above reviewed studies was that they were not 
able to determine whether the mother actually was infected or not. To 
overcome this problem, Mednick et al 1994 (23) obtained data on 
maternal infection and its timing during pregnancy from prenatal clinic 
records. A significantly higher rate of definite influenza infections was 
found in patients with schizophrenia exposed during the second trimester 
(86.7%) than in those exposed during the rest of the pregnancy (20%). 
Another research group (24) used a similar study design, obtaining data 
on different maternal respiratory infections from the gravida’s Health 
Plan charts. An association was found between second trimester 
exposure to respiratory infections and risk for schizophrenia spectrum 
disorders (RR 2.13, 95% CI 1.05-4.35), whereas exposure during first 
and third trimesters had no impact on the risk. 
 
The relationship between prenatal exposure to maternal 
genital/reproductive infections and the offspring’s risk of schizophrenia 
has also been studied (25). Exposure data were obtained from 
diagnoses made by physicians during obstetric and medical visits. 
Periconceptional exposure to genital/reproductive infections was related 
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to an increased risk of schizophrenia spectrum disorders (OR 5.03, 95% 
CI 2.00-12.64). 
 
One study (26) obtained the data on prenatal exposure to maternal 
bacterial infections by interviewing the mothers five days after delivery 
and at their first antenatal clinic visit. The effect of the exposure on the 
risk for both ICD-8 and broadly defined (ICD-8 and ICD-10) 
schizophrenia in the offspring was examined. Exposure during the first 
trimester was associated with an increased risk for both of them (OR 
2.53, 95% CI 1.07-5.96 and OR 2.14, 95% CI 1.06-4.31, respectively). 
 
In contrast to other studies, positive family history of psychotic disorders 
was sought to be taken into account by calculating the biological 
synergism between it and prenatal infection exposure on affecting the 
offspring’s risk for schizophrenia. Acute pyelonephritis leading to the 
hospitalization of the mother was chosen as the prenatal infectious 
exposure for the study. The exposure data, together with the data on the 
family history of psychiatric diseases, was obtained from national 
registries. The authors found that prenatal pyelonephritis exposure was 
five times greater in those individuals having positive family history of 
psychosis compared to those who did not. While no significant increase 
in the risk of schizophrenia after the exposure to maternal pyelonephritis 
alone was found, the synergy analysis suggested an estimated 38%-46% 
of the offspring with schizophrenia to have developed the disorder as a 
result of synergism between both of the factors. 
 
One study (28) sought to determine whether the effect of prenatal 
exposure to different infections on the offspring’s schizophrenia risk was 
different from that of prenatal exposure to paternal infections or parental 
infections in general. Infection data was obtained from national hospital 
register diagnoses. No significant differences between these different 
types of exposures were found (parental infection: incidence rate ratio 
IRR 1.23, 95% CI 1.04-1.44; paternal infection: IRR 1.31, 95% 0.87-
1.88). 
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The relationship between different complications during pregnancy and 
delivery, and schizophrenia risk in a group of children with mothers 
having schizophrenia spectrum disorders was examined (29), using the 
obstetric records as the source of complication data. Prenatal exposure 
to maternal infections was associated with an elevated risk of 
schizophrenia spectrum disorders in the offspring of mothers having 
schizophrenia spectrum disorders (HRR 3.73, 95% CI 1.27-11.01). Also, 
mothers having schizophrenia spectrum disorder during pregnancy had a 
higher rate of infections during pregnancy compared to those developing 
the disorder after the pregnancy (19.0% vs 9.3%, respectively). Thus, 
prenatal maternal infections might be among the mechanisms by which 
the maternal history of schizophrenia spectrum disorders elevates the 
offspring’s risk for developing schizophrenia spectrum disorders. 
 
 
Majority of the more recent studies in humans have used a more 
accurate approach, determining the prenatal exposure to maternal 
infections and immune response by assaying maternal serum samples 
collected during pregnancy. Because prenatal exposure to several 
different infectious agents had been found to be associated with 
increased risk to schizophrenia spectrum disorders, the serum levels of 
four cytokines elevated in infectious and inflammatory processes during 
the second trimester were investigated (30). The authors found that 
serum levels of IL-8 were significantly elevated in mothers of subjects 
than controls during the second trimester, whereas no differences in the 
levels of IL-1β, IL-6, or TNF-α were detected. 
 
Another study (31) studied the effect of prenatal exposure to maternal 
influenza on the risk for schizophrenia spectrum disorders in the 
offspring. The exposure was determined by assaying maternal sera for 
influenza antibody, and results showed a seven-fold increase (OR 7.0, 
95% CI 0.7-75.3) in risk when exposed during the first trimester, whereas 
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no association to the risk was observed after second- or third-trimester 
exposures. However, this finding did not achieve statistical significance 
(p=.08). The risk was increased three-fold (OR 3.0, 95% CI 0.9-10.1, 
p=.52) when using a gestational period from early to mid-pregnancy. 
 
Also the effect of prenatal exposure to maternal herpes simplex virus 2 
(HSV-2) infections on the offspring’s risk for schizophrenia spectrum 
disorder has been examined (32). The research group assayed maternal 
sera from late pregnancy for IgG antibody to HSV-2, but no association 
(OR 1.04, 95% CI 0.76-1.43) with schizophrenia spectrum disorder risk 
was found.  
 
The aim of one study by Brown et al. (33) was to examine whether 
prenatal exposure to maternal influenza or toxoplasmosis was 
associated with executive dysfunction in schizophrenic offspring. 
Maternal sera were assayed to determine the prenatally exposed vs. 
non-exposed subjects, and a neurophysiological test battery was used as 
a measure of executive functions. The results showed decreased skills in 
executive functions in most of the conducted tests among the exposed 
(serologically documented exposure to either influenza or toxoplasmosis 
during the first half of the pregnancy) patients compared to the non-
exposed group. 
 
A recent study (34) examined the association between the early 
gestational level of C-reactive protein (CRP) in the maternal serum 
samples and the risk of schizophrenia in the offspring. A significant 
association was found between increasing maternal CRP levels and 
schizophrenia prevalence in the offspring (OR 1.31, 95% CI 1.10-1.56). 
According to the authors, their findings provide the most robust evidence 
to date that maternal inflammation may play a significant role in 
schizophrenia. This was rationalized with a large, prospectively collected 
sample (N= over 700 cases and 700 controls), ascertainment of the 
schizophrenia diagnoses from national Finnish registers, and 
quantification of CRP levels from maternal serum samples. In addition, 
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the findings were not confounded by maternal age or education, previous 
births, parental psychiatric disorders, urbanicity, province of birth, 
twin/singleton status, or gestational week of the blood draw.   
 
 
Schizoprenia Spectrum Disorders (SSDs) 
Reference Objective Sample Method Diagnosis/sy
mptomatology 
Key findings 
Mednick et 
al. 1994 
To examine the 
association 
between maternal 
influenza infection 
during second 
trimester and the 
offspring’s risk of 
schizophrenia. 
N=25 
participants 
with 
schizophrenia 
from Helsinki 
born 1957-
1958. 
Reading of 
prenatal clinic 
records to 
determine the 
timing of 
maternal 
infection noted 
by obstetrical 
nurse. 
 Participants with 
schizophrenia 
exposed during the 
second trimester 
had a significantly 
higher rate of 
definite influenza 
infection (86.7%) 
compared to those 
exposed during the 
first and third 
trimesters (20%). 
O’Callaghan 
et al. 1994 
To examine the 
relationship 
between deaths 
from 16 different 
infectious 
diseases and 
births of 
individuals with 
schizophrenia. 
Two 
independent 
sets of birth 
dates; 
Sample 1:  
N=6982 
patients with 
schizophrenia 
born between 
1938 and 1965 
in England and 
Wales. 
Sample 2: 
N=9585 
persons born 
between 1938 
and 1958 in 
England and 
Wales having a 
diagnosis of 
schizophrenia. 
The 
association 
between 
deaths from 16 
infectious 
diseases was 
obtained from 
the Registrar 
General’s 
Annual Review 
of Statistics. 
Poisson 
regression 
model was 
used for data 
analysis. 
Diagnosis of 
schizophrenia 
was based on 
ICD-8 or -9. 
National deaths 
from 
bronchopneumonia 
preceded births of 
individuals with 
schizophrenia, by 
three and five 
months respectively, 
in both of the two 
data sets. No 
association was 
found with the 15 
other infectious 
diseases. 
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Venables et 
al. 1996 
To examine 
whether exposure 
to maternal 
influenza during 
the second 
trimester is an 
individual risk 
factor for 
schizotypy or 
confounded with 
the effect of cold 
temperature. 
N=771 (405 
male and 366 
female) 
participants of 
the Mauritius 
Project. 
Influenza 
exposure data 
were obtained 
from 
newspaper 
records and 
Mauritian 
Registrar 
General’s 
Department 
death causes.  
Schizotypy 
was 
measured by 
a scale 
having a two-
factor 
structure, 
positive 
symptoms 
labeled as 
Schizophrenis
m (SZ) and 
negative 
symptoms 
defined as 
physical and 
social 
anhedonia 
(AH). 
The results suggest 
that prenatal 
exposure to 
influenza is 
associated with an 
elevation of 
schizophrenism, 
whereas exposure 
to low temperatures 
is associated with 
an elevation of 
anhedonia scores in 
the offspring. 
Takei et al. 
1996 
To examine the 
relationship 
between in utero 
exposure to 
influenza 
epidemics and 
schizophrenia. 
N=9462 
patients with 
schizophrenia 
born between 
1915 and 1970 
in Denmark. 
Influenza 
exposure data 
was obtained 
from Serum 
Institute, 
Copenhagen. 
Poisson 
regression 
analysis was 
used for data 
analysis. 
Diagnosis of 
schizophrenia 
was based on 
ICD-8 (code 
295.0-9). 
Influenza exposure 
four months prior to 
birth was associated 
with a significantly 
increased risk of 
schizophrenia (RR 
1.12, 95% CI 1.01-
1.24). 
Battle et al. 
1999 
To examine 
seasonal and 
maternal infectious 
disease influences 
on schizophrenia 
prevalence.  
N=11,736 
participants 
with 
schizophrenia 
and N=734,879 
participants 
without 
schizophrenia 
from Georgia 
Medicaid 
database. 
Statewide 
infectious 
disease tables 
were used to 
identify 
correlations 
with births of 
individuals with 
schizophrenia. 
Multiple 
regression 
analyses were 
used. 
Diagnosis of 
schizophrenia 
was based on 
ICD-9 (code 
295.xx). 
A significant 
relationship 
between winter 
season and 
schizophrenia 
incidence was 
found, whereas 
exposure to neither 
maternal influenza 
nor measles was 
predictive of 
schizophrenia 
prevalence. 
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Westergaard 
et al. 1999 
To examine the 
possible influence 
on schizophrenia 
prevalence of 
sibship 
characteristics and 
ecological 
influenza exposure 
data. 
N=1 746 366 
persons’ 
Danish 
population-
based cohort, 
of which 
N=2669 
participants 
with 
schizophrenia. 
The monthly 
numbers of 
influenza cases 
was obtained 
from the 
National Board 
of Health 
(1950-1979) 
and Statens 
Serum Institut 
(1980-1988). 
Sibship 
characteristics 
were calculated 
from data 
obtained from 
the Civil 
Registration 
System. 
Diagnosis of 
schizophrenia 
was based on 
ICD-8 (code 
295). 
No association 
between birth order 
or influenza 
prevalence and risk 
of schizophrenia. 
Risk for 
schizophrenia was 
increased in 
individuals coming 
from a large (4/5 or 
more) sibship (RR 
1.26, 95% CI 1.11-
1.44/RR 1.46, 95% 
CI 1.22-1.75, 
respectively) and 
short intervals (<2 
years) to the 
nearest younger or 
older siblings (RR 
1.15, 95% CI 1.03-
1.28/RR 1.22, 95% 
CI 1.05-1.38, 
respectively). 
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Brown et al. 
2000 
To examine the 
relationship 
between maternal 
exposure to 
respiratory 
infections and the 
offspring’s 
schizophrenia 
spectrum 
disorders. 
N=58 
individuals with 
SSD and N=7 
725 without 
SSD of the 
Prenatal 
Determinants 
of 
Schizophrenia 
(PDS) Study 
cohort. 
Data on 
maternal 
medical 
conditions were 
obtained from 
the gravidas’ 
Health Plan 
charts. The 
data were 
analyzed using 
proportional 
hazards 
regression. 
Analyses were 
adjusted for 
maternal 
smoking, 
education and 
race. 
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
Health Plan 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
Second trimester 
exposure to 
respiratory 
infections was 
associated with a 
significantly 
increased risk of 
SSDs (RR 2.13, 
95% CI 1.05-4.35), 
no associations 
were shown for first 
and third trimester 
exposures. 
Limosin et al. 
2002 
To examine the 
relationship 
between 
gestational 
influenza virus 
exposure and risk 
of schizophrenia. 
N=974 adults 
with 
schizophrenia 
born between 
1949 and 1981 
and their 
siblings without 
schizophrenia 
born between 
1949 and 1981 
(N=1589). 
N=974 
matched 
controls. 
Risk of 
exposure to the 
influenza virus 
was 
determined 
using data from 
French 
National Health 
and Medical 
Research 
Institute 
(INSERM) and 
French 
National 
Institute for 
Statistics and 
Economic 
Studies.  
Diagnosis of 
schizophrenia 
was based on 
DSM-IV 
criteria. 
Significantly more 
participants with 
schizophrenia than 
controls had been 
exposed to the 
influenza virus 
during the fifth 
month of pregnancy 
(OR 2.24, 95% CI 
1.49–3.35, and OR 
1.61, 95% CI 1.04–
2.49). 
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Brown et al. 
2004 
To examine the 
relationship 
between maternal 
levels of four 
cytokines (IL-8, IL-
1β, IL-6 and TNF-
α) during the 
second trimester 
and the offspring’s 
risk for 
schizophrenia. 
N=59 
participants 
with SSD and 
N=105 controls 
from a birth 
cohort born 
between 1959 
and 1967. 
Cytokine levels 
were 
determined 
from maternal 
sera by 
sandwich 
enzyme-linked 
immunosorbent 
assay. 
Conditional 
logistic 
regression 
models were 
used to 
estimate the 
association 
between each 
cytokine and 
SSDs, 
adjusting for 
maternal age, 
maternal 
ethnicity, 
socioeconomic 
status, 
maternal 
smoking and 
gestational age 
of the sample. 
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
inpatient, 
outpatient 
and 
pharmacy 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
The second-
trimester IL-8 levels 
were significantly 
higher in mothers of 
individuals with SSD 
than in comparison 
subjects. No 
differences were 
found between 
individuals with SSD 
and controls with 
respect to maternal 
levels of IL-1β, IL-6 
or TNF-α. 
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Brown et al. 
2004 
To examine 
whether 
serologically 
documented 
prenatal exposure 
to influenza 
increases the risk 
of schizophrenia 
spectrum 
disorders. 
N=64 
individuals with 
SSD and 
N=125 controls 
from a large 
birth cohort 
born between 
1959 and 1966. 
Influenza 
exposure was 
determined by 
assaying 
maternal sera 
for influenza 
antibody. 
Conditional 
regression 
models were 
used, adjusting 
for maternal 
education, 
maternal age, 
paternal age, 
race, sex and 
number of 
maternal serum 
samples 
drawn. 
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
inpatient, 
outpatient 
and 
pharmacy 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
The risk of SSDs 
was increased 
sevenfold for first-
trimester influenza 
exposure. No 
increased risk was 
found with influenza 
during the second or 
third trimesters. 
Using a broader 
gestational period - 
early to 
midpregnancy - the 
risk of SSDs was 
increased threefold. 
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Babulas et 
al. 2006 
To examine the 
relationship 
between exposure 
to maternal 
genital/reproductiv
e infections and 
SSDs in the 
offspring. 
N=7 794 
offspring of 
pregnancies 
with 
prospectively 
acquired data 
on maternal 
G/R infections 
from obstetric 
records of 
which N=71 
individuals with 
SSD. 
Data on 
maternal 
genital/reprodu
ctive infections 
were obtained 
from physician 
diagnoses 
made during 
obstetric and 
medical visits. 
Data were 
analyzed with 
Cox 
proportional 
hazards 
regression. 
Analyses were 
adjusted for 
maternal age, 
race, education 
and mental 
illness.  
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
inpatient, 
outpatient 
and 
pharmacy 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
Exposure to 
genital/reproductive 
infections during the 
periconceptional 
period was 
associated with 
significantly 
increased risk for 
SSDs (RR 5.03, 
95% CI 2.00-12.64).  
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Brown et al. 
2006 
To examine 
whether maternal 
exposure to 
Herpes Simplex 
Virus 2 is 
associated with 
risk for adult 
schizophrenia. 
N=60 
individuals with 
SSD and 
N=110 controls 
from a large 
birth cohort 
born between 
1959 and 1967. 
Archived 
maternal sera 
from late 
pregnancy 
were assayed 
by enzyme-
linked 
immunosorbent 
assay for IgG 
antibody to 
HSV-2. 
Conditional 
logistic 
regression 
models were 
used for data 
analysis, 
adjusting for 
maternal 
ethnicity and 
maternal 
education. 
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
inpatient, 
outpatient 
and 
pharmacy 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
No associations 
were found between 
maternal IgG 
seropositivity or 
antibody levels to 
HSV-2 and the 
offspring’s risk of 
SSDs. 
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Sørensen et 
al. 2008 
To examine the 
relationship 
between maternal 
bacterial infection 
and risk of 
schizophrenia in 
the offspring. 
N=4030 males 
and N=3911 
females from 
Copenhagen 
Prenatal 
Cohort with 
data on 
prenatal 
exposure to 
infection. 
Data on 
prenatal 
bacterial 
infections were 
obtained by 
interviewing the 
mothers five 
days after 
delivery and 
67% at their 
first visit to the 
antenatal clinic. 
Multivariate 
models were 
used for data 
analysis, 
adjusting for 
social status 
and exposure 
to analgesics 
during 
pregnancy. 
Diagnoses 
were obtained 
from Danish 
Psychiatric 
Central 
Research 
Register 
which used 
ICD-8 until 
1993 and 
ICD-10 since 
1994 (codes 
295/F20, 
respectively). 
ICD-8 
diagnosis was 
defined as 
narrow, more 
broadly 
defined 
diagnosis 
included both 
ICD-8 and -10 
systems. 
First-trimester 
exposure conferred 
an elevated risk of 
both ICD-8 and 
broadly defined 
schizophrenia (OR 
2.53, 95% CI 1.07-
5.96 and OR 2.14, 
95% CI 1.06-4.31, 
respectively).  
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Brown et al. 
2009 
To examine 
whether exposure 
to prenatal 
infection is 
associated with 
executive 
dysfunction in 
patients with SSD. 
N=26 patients 
with SSD 
exposed to 
prenatal 
maternal 
infection and 
N=24 non-
exposed 
controls with 
SSD from a 
large birth 
cohort.  
Data on 
exposure to 
influenza and 
toxoplasmosis 
were obtained 
from maternal 
sera. Executive 
function was 
measured by a 
neuropsycholo
gical battery 
including 
several tests. 
SSD was 
defined as 
schizophrenia
, delusional 
disorder, 
psychotic 
disorder not 
otherwise 
specified, 
schizoaffectiv
e disorder 
and 
schizotypal 
personality. 
Diagnoses 
were 
ascertained 
by a three-
step 
procedure 
including 1) 
ascertainment 
of psychiatric 
treatment by 
inpatient, 
outpatient 
and 
pharmacy 
registries; 2) 
identifying 
potential SSD 
cases; 3) 
interviewing 
the potential 
cases with 
the 
Diagnostic 
Interview for 
Genetic 
Studies 
(DIGS)/diagn
osis based on 
chart review.  
Patients exposed to 
infection in utero 
committed 
significantly more 
total errors on the 
Wisconsin Card 
Sorting Test and 
took significantly 
more time to 
complete the Trails 
B than unexposed 
patients. Exposed 
patients also 
exhibited deficits on 
figural fluency, 
letter-number 
sequencing and 
backward digit span. 
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Clarke et al. 
2009 
To examine 
whether prenatal 
exposure to 
infection and 
positive family 
history of 
psychotic 
disorders interact 
synergistically to 
increase the risk of 
later 
schizophrenia. 
N=9 596 
women who 
received 
hospital 
treatment 
during 
pregnancy for 
an upper 
urinary tract 
infection in 
Helsinki 1947-
1990. 
The Medical 
Birth Register 
and the Finnish 
Population 
Register were 
linked to 
identify all 
individuals 
whose mothers 
were 
hospitalized 
during 
pregnancy for 
acute 
pyelonephritis. 
An additive 
statistical 
interaction 
model was 
used to 
calculate the 
amount of 
biological 
synergism 
between 
positive family 
history and 
prenatal 
exposure to 
infection. 
Schizophreni
a diagnoses 
for exposed 
and their 
families were 
obtained from 
Finnish 
Hospital 
Discharge 
Register, 
which has 
used ICD-8 
(before 1987), 
ICD-9 (1987-
1995) and 
ICD-10 (since 
1995), code 
295 in ICD-8 
and -9/F20 in 
ICD-10. 
Prenatal exposure 
to pyelonephritis 
was five times 
greater in those who 
had a family history 
of psychosis 
compared to those 
who did not. 
Prenatal exposure 
to infection alone 
did not significantly 
increase the risk of 
schizophrenia. The 
synergy analysis 
suggested that an 
estimated 38%-46% 
of the offspring who 
developed 
schizophrenia did so 
as a result of the 
synergistic action of 
both risk factors.  
Nielsen et al. 
2011 
To examine the 
relationship 
between maternal 
infections during 
pregnancy or 
parental infections 
in general and risk 
for schizophrenia 
in the offspring. 
All singletons 
born in 
Denmark 1978-
1998 who were 
alive at their 
10th birthday 
and whose 
mothers were 
born in 
Denmark (N=1 
115 752).  
Data on 
infections were 
obtained from 
the Danish 
National 
Hospital 
Register, 
coded by ICD-
8/ICD-10 
systems. 
Poisson 
regression 
model was 
used for data 
analysis, 
adjusting 
relative risks 
for calendar 
year, age, sex 
and history of 
schizophrenia, 
schizophrenia-
like psychosis 
or psychiatric 
hospital contact 
in a parent. 
Schizophreni
a diagnoses 
were obtained 
from the 
Danish 
Psychiatric 
Central 
Research 
Register, 
which used 
ICD-8/ICD-10 
(codes 295 
and F20, 
respectively). 
A slightly increased 
risk of schizophrenia 
was found after 
prenatal infection 
exposure, but it was 
not significantly 
different from the 
effect of infection in 
general. 
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Suvisaari et 
al. 2013 
To compare the 
occurrence of 
obstetric 
complications in 
children of 
mothers with SSD 
and control 
children, and to 
investigate 
whether obstetric 
complications 
predicted 
children’s 
psychiatric 
morbidity. 
N=271 HR 
(Helsinki High-
Risk) Study 
offspring with 
mothers having 
SSD and 
N=242 control 
offspring. 
Data on 
obstetric 
complications 
were obtained 
from obstetric 
records. A Cox 
regression 
model was 
used for data 
analysis. 
Information 
on mental 
disorders was 
obtained from 
the Finnish 
Hospital 
Discharge 
Register. 
Diagnoses 
were based 
on DSM-IV 
criteria. For 
individuals 
with psychotic 
and mood 
disorders, 
also the 
Operational 
Criteria 
Checklist for 
Psychotic 
Illness and 
the Major 
Symptoms of 
Schizophreni
a Scale was 
completed. 
Infections (HRR 
3.73, 95% CI 1.27– 
11.01), hypertension 
during pregnancy 
(HRR 4.10, 95% CI 
1.15–14.58), and 
placental 
abnormalities (HRR 
4.09, 95% CI 1.59–
10.49) were 
associated with 
elevated risk of 
SSDs within the HR 
group. 
Canetta et al. 
2014 
To examine the 
relationship 
between maternal 
early gestational 
C-reactive protein 
and schizophrenia. 
N=777 
individuals with 
schizophrenia 
and N=777 
matched 
controls from 
the Finnish 
Prenatal Study 
of 
Schizophrenia 
cohort. 
C-reactive 
protein levels 
from maternal 
serum 
specimens 
were assessed 
using a latex 
immunoassay. 
Analyses were 
adjusted for 
maternal and 
parental history 
of psychiatric 
disorders, 
twin/singleton 
birth, 
urbanicity, 
province of 
birth and 
maternal 
socioeconomic 
status.  
Diagnoses of 
schizophrenia 
(code F20) or 
schizoaffectiv
e disorder 
(F25) were 
based on 
ICD-10.  
Increasing maternal 
C-reactive protein 
levels were 
significantly 
associated with 
schizophrenia in the 
offspring (OR=1.31, 
95% CI=1.10–1.56). 
IL-1β, Interleukin 1β IL-4 Interleukin 4; IL-6, Interleukin 6; TNF-α, Tumor Necrosis Factor α 
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Animal studies 
 
The use of serological assays has increased the reliability of 
determination of the prenatal exposure to infectious agents and 
inflammatory processes. However, they do not provide information about 
the mechanisms by which the exposure elevates the risk for 
schizophrenia spectrum disorders. For this purpose, animal models have 
been used. To mimic viral infection, mostly synthetic double-strand RNA 
polyriboinosinic-polyribocytidilic acid (poly I:C) has been used due to its 
advantages compared to viral infection.  Advantages include the elicited 
nonspecific immune response common to various viruses and no virus-
specific organ diseases, which could affect embryonal brain development 
(35-36). The models mimicking bacterial infection use mostly 
lipopolysaccharide (37-38), an endotoxin present on the outer membrane 
of gram-negative bacteria, to initiate the bacterial immune response.  
 
Fatemi et al 1999 (39) focused on a finding from postmortem human 
brains of patients with schizophrenia (40) by investigating the reduced 
expression of reelin protein in the cells of layer I of neocortex. The 
offspring of mice prenatally infected with influenza virus showed 
significant reductions in reelin expression in neocortical layer I and also 
other cortical and hippocampal layers compared to non-exposed controls 
(39). Additionally, the thicknesses of the neocortex and hippocampus 
were reduced in the exposed offspring. 
 
In human studies, loss of dendrites and spines (41-42) in the prefrontal 
cortex has been observed in patients with schizophrenia. A rat study (43) 
examined whether prenatal exposure to three cytokines - IL-1β, TNF-α, 
IL-6 - affected the number of primary dendrites, nodes and total dendrite 
length in the offspring of exposed rats. TNF-α and the combination of IL-
1β and TNF-α both significantly reduced the total dendritic length (14% 
and 30%, respectively) and the number of nodes (27% and 32%, 
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respectively). In addition, IL-1β + TNF-α reduced the number of primary 
dendrites (17%).  
 
The aim of one study (44) was to elucidate the site of action of exposure 
to prenatal maternal lipopolysaccharide challenge in increasing the 
schizophrenia risk in the offspring. For this purpose, lipopolysaccharide 
was iodinated and injected into pregnant rats. Its distribution, together 
with the measurement of the induction of IL-1β, TNF-α and IL-6 
cytokines, was assessed in both maternal and fetal rat tissues. 
Lipopolysaccharide, as well as increases in IL-1β, IL-6 and TNF-α, was 
detected in maternal plasma and placenta, but not the fetal brain or liver. 
However, significant increase in IL-1β was detected in fetal plasma. 
Thus, the authors suggested that the actions of lipopolysaccharide in 
increasing the schizophrenia risk act indirectly.  
 
In one study (45), the effect of prenatal poly (I:C) injection into pregnant 
mice on the offspring’s the dopaminergic function was examined. 
Dopaminergic neurotransmitter function has been found to be impaired in 
patients with schizophrenia (46-47). Because cognitive dysfunction (48-
49) and deficits in sensory motor gating (50) have been found in 
schizophrenic patients, also these were evaluated. In the juvenile stage, 
no differences were observed between the exposed and control 
offspring, whereas in adult offspring, the cognitive impairment and 
increased subcortical dopamine function were detected. Dopaminergic 
function in the offspring after poly (I:C) injection into pregnant mice was 
determined in another study (51). Dopaminergic maldevelopment starting 
in the fetal stages of life and depending on postnatal maturational 
processes was found in the exposed offspring.  
 
Evidence for an involvement of oligodendrocytes and abnormal 
myelination in the prefrontal cortex and hippocampus in the 
pathophysiology of schizophrenia has been reported (52-57). Therefore, 
the effect of poly (I:C) injection into pregnant mice on these two factors in 
the offspring was the focus of an animal study (58). At early postnatal 
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periods, a significant decrease of myelin basic protein mRNA and protein 
was detected in the exposed offspring, but no significant loss of 
oligodendrocytes was observed. However, at the adult stages of life, 
these abnormalities were reverted to normal levels. 
 
Postmortem studies on human brains of individuals with schizophrenia 
have showed impairments in the GABAergic function in the hippocampus 
(59-61). Therefore, the effect of poly (I:C) injection into pregnant mice on 
the hippocampal GABAergic neurotransmission in the offspring was 
determined (62), and abnormalities in the exposed subjects’ 
hippocampal area CA1 was found. 
 
It has been shown that patients with schizophrenia exhibit impairments in 
prepulse inhibition (63) and HPA-axis function (64). A group of 
researchers (65) aimed to determine the relationship between prenatal 
poly (I:C) injection into pregnant rats and these two factors in the 
offspring. Part of the pregnant rats were pretreated with the neurosteroid 
dehydroepiandrosterone (DHEA), which modulates the neuronal activity 
of several receptors in the brain (66) and appear to attenuate the severity 
of psychosis (67). The results showed alterations in prepulse inhibition 
and reduced HPA-axis response to stress in the exposed offspring. 
However, DHEA pretreatment reversed the effect of poly (I:C) treatment 
on prepulse inhibition in female offspring, and abnormal HPA-axis stress 
response was normalized in all offspring pretreated with DHEA. 
 
Multiple metabolic abnormalities have been detected in drug-naive 
patients with schizophrenia, indicating a possible developmental origin. 
These abnormalities include impaired glucose tolerance (68), increased 
visceral and subcutaneous fat deposition (69), abnormal ingestive 
behavior (70) and increased peripheral corticosterone release (64). 
Therefore, the effect of prenatal poly (I:C) injection to pregnant mice on 
these metabolic abnormalities in the offspring was investigated (71). All 
the four were found in the exposed offspring either in periadolesence or 
in adulthood. Additionally, decreased release of proinflammatory IL-6 and 
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TNF-α and T-cell related IL-2 and IFN-γ cytokines, possibly underlying 
the excessive food and fluid intake, were detected. 
 
The impact of maternal immune activation induced in mice by poly (I:C), 
influenza virus and IL-6 at day 9.5 on the fetal brain transcriptome was 
studied (72), specifically looking at the crystallin genes related to 
schizophrenia (73-75) and autism (76) risk. An acute and transient 
upregulation of the α, β and γ crystallin gene family was detected, and 
the levels of their expression were associated with the severity of 
maternal immune activation.  
 
Using both a set of behavioral tests and brain investigation of neonatal 
rats, the potential effects of prenatal exposure to maternal LPS challenge 
at gestational days 15 and 16 on early neurophenotypic presentations 
seen in schizophrenia and autism were examined (77). The 
lipopolysaccharide exposed pups showed a significant decrease in the 
number and duration of ultrasonic vocalizations at 3rd and 5th postnatal 
days P3 and P5, as well as impairments in nest-seeking behaviors and 
odor-stroke associative learning at 8th and 9th postnatal days. In the 
brain investigation, significant decrease in the 5-HT1A and 5-HT1B 
expression at 3rd postnatal day was found. All these findings suggest a 
role of prenatal exposure to an immune activator in increasing the risk for 
schizophrenia and autism. 
 
3.2 Autism Spectrum Disorders  
 
Like schizophrenia, also autism spectrum disorders have attracted 
researchers’ attention regarding prenatal exposure to maternal infection 
and immune response as risk factors. Both human and animal studies 
have been conducted to investigate the topic. 
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Human studies 
 
The effect of prenatal exposure to maternal infections requiring 
hospitalization on the risk for autism spectrum disorders was examined 
by Atladóttir et al 2010 (78). They assessed at both viral and bacterial 
exposures. First-trimester hospitalization due to maternal viral infection 
was associated with an increased risk of autism spectrum disorders in 
offspring (HR 2.98, 95% CI 1.29-7.15), as was second-trimester 
hospitalization due to maternal bacterial infection (HR 1.42, 95% CI 1.08-
1.87). However, when the pregnancy was assessed as a whole, no 
associations were found with either exposure. Because pathogens 
underlying different viral and bacterial infections were not separated in 
these analyses, the findings suggest a role of maternal immune 
activation rather than the pathogen itself in elevating the offspring’s risk 
for autism spectrum disorders. 
 
Maternal influenza and fever were chosen as exposures in another study 
(79). They sought to determine their potential effect on autism spectrum 
disorder risk in offspring. Influenza and fever exposures were obtained 
by telephone interviews. The results showed no association between 
prenatal exposure to maternal influenza and risk for autism spectrum 
disorders in the offspring, but exposure to maternal fever was associated 
with an elevated risk (OR 2.12, 95% CI 1.17-3.84). This risk was 
attenuated if the mother had taken antipyretic medication (OR 1.30, 95% 
CI 0.59-2.84), but remained elevated for the offspring of those mothers 
who did not (OR 2.55, 95% CI 1.30-4.99), indicating that exposure to 
maternal infections and inflammation acts through an indirect pathway in 
elevating the risk for autism in the offspring, i.e. the pathogen itself does 
not affect the developing nervous system but the symptom it causes, 
fever, does. 
 
In another study by Atladóttir et al 2012 (80), the impact of prenatal 
exposure to common infections, febrile episodes and use of antibiotics 
on autism spectrum disorder and infantile autism risk in the offspring was 
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determined. Exposure data were obtained by telephone interviews with 
the mother during pregnancy and early postpartum. Results showed only 
little evidence for an association between mild infections or short febrile 
episodes and risk for autism spectrum disorders or infantile autism. 
However, exposure to maternal influenza elevated the risk significantly 
(HR 2.3, 95% CI 1.0-5.3). Moreover, prolonged febrile episodes were 
associated with an increased risk of infantile autism (HR 3.2, 95% CI 1.8-
5.6) and use of antibiotics during pregnancy was a potential risk factor for 
both autism spectrum disorders and infantile autism. However, due to 
multiple testing, the authors emphasized that the significant findings may 
be due to a chance and the negative findings need to be further 
investigated. 
 
Maternal serum samples have been utilized in a study (81), which 
increases the reliability of exposure data. The levels of C-reactive protein 
(CRP) were assessed from maternal serum specimens and categorized 
in quintiles for the examination of the relationship between prenatal 
exposure to maternal CRP and risk of childhood autism in the offspring. 
When comparing the risks between the quintiles, an increased risk was 
found between the highest and lowest quintiles (OR 1.43, 95% CI 1.02-
2.01). Thus, elevated CRP levels seemed to be associated with an 
increased risk of autism in the offspring, suggesting a common pathway 
by which various maternal infectious and inflammatory exposures elevate 
the risk of autism.  
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Autism Spectrum Disorders (ASDs) 
Reference Objective Sample Method Diagnosis/sy
mptomatology 
Key findings 
Atladóttir et 
al. 2010 
To examine the 
relationship 
between maternal 
infections requiring 
hospitalization 
during pregnancy 
and autism 
spectrum 
disorders in the 
offspring. 
All children 
born in 
Denmark 1980-
2005 (N= 1 612 
342). 
Exposure data 
were obtained 
from Danish 
National 
Hospital 
Register. 
Analyses were 
adjusted for 
sex, paternal 
age, parity and 
parental history 
of psychiatric 
disorder. 
ASD 
diagnoses 
were obtained 
from the 
Danish 
Psychiatric 
Central 
Register, 
which used 
ICD-8 1969-
1993 and 
ICD-10 since 
1994 (ICD-8 
codes: 
299.00, 
299.01, 
299.02, 
299.03 and 
ICD-10 
codes: F84.0, 
F84.1, F84.5, 
F84.8, and 
F84.9). 
Admission to 
hospital due to 
maternal viral 
infection during the 
first trimester and 
maternal bacterial 
infection during the 
second trimester 
were found to be 
associated with 
ASDs in the 
offspring. No 
associations were 
found when the total 
period of pregnancy 
was used (HR 2.98, 
95% CI 1.29–7.15 
and HR 1.42, CI 
1.08–1.87, 
respectively). 
Zerbo et al. 
2012 
To examine the 
relationship 
between maternal 
influenza or fever 
during pregnancy 
and the offspring’s 
risk for ASDs or 
developmental 
delays. 
N=538 children 
with ASD, 
N=163 with 
developmental 
delay and 
N=421 typically 
developing 
children. 
Exposure data 
were obtained 
by telephone 
interviews. 
Multivariate 
regression 
models were 
used for data 
analysis, 
adjusting for 
maternal age, 
maternal 
education, 
place of 
residence, 
maternal 
smoking, 
periconception
al vitamin 
supplementatio
n, parity, type 
of health 
insurance 
coverage, sex 
and race. 
ASD/develop
mental delay 
diagnoses 
were clinically 
confirmed by 
the Mullen 
Scales of 
Early 
Learning, 
Vineland 
Adaptive 
Behavior 
Scales, 
Autism 
Diagnostic 
Interview-
Revised and -
Generic. 
Neither ASDs nor 
developmental 
delay were 
associated with 
influenza, but both 
were associated 
with maternal fever 
(OR 2.12, 95% CI 
1.17-3.84 and OR 
2.50, 95% CI 1.20-
5.20, respectively). 
The fever-
associated risk of 
ASDs was 
attenuated among 
mothers who 
reported taking 
antipyretic 
medications (OR 
1.30, 95% CI 0.59-
2.84), but remained 
elevated for those 
who did not (OR 
2.55, 95% CI 1.30-
4.99). 
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Atladóttir et 
al. 2012 
To determine the 
occurrence of 
common 
infections, febrile 
episodes, and use 
of antibiotics 
reported by the 
mother during 
pregnancy and the 
risk of ASDs and 
infantile autism in 
the offspring. 
N=96 736 
participants 
from a 
population-
based cohort 
consisting of 
children aged 
8-14 years and 
born 1997-
2003 in 
Denmark. 
Information on 
infection, 
febrile 
episodes and 
use of 
antibiotics was 
self-reported 
trough 
telephone 
interviews 
during 
pregnancy and 
early 
postpartum. 
Cox 
proportional 
hazards 
regression 
model was 
used for data 
analysis, 
adjusting for 
sex, maternal 
age, parity, 
maternal 
smoking, 
paternal age, 
parental 
psychiatric 
history and 
parents’ 
educational 
status. 
Diagnoses of 
ASDs and 
infantile 
autism were 
retrieved from 
the Danish 
Psychiatric 
Central 
Register 
using ICD-10 
(codes F84.0, 
F84.1, F84.5, 
F84.8 and 
F84.9). 
Little evidence was 
found that various 
mild infections or 
febrile episodes 
were associated 
with ASDs/infantile 
autism. Maternal 
influenza infection 
was however 
associated with a 
twofold increased 
risk of infantile 
autism (HR 2.3, 
95% CI 1.0-5.3), 
prolonged febrile 
episodes with a 
threefold increased 
risk of infantile 
autism (HR 3.2, 
95% CI 1.8-5.6) and 
use of various 
antibiotics during 
pregnancy were 
potential risk factors 
for ASDs/infantile 
autism. 
Brown et al. 
2013 
To examine the 
relationship 
between maternal 
early gestational 
C-reactive protein 
and childhood 
autism. 
N=677 
individuals with 
autism and 
N=677 
matched 
controls from a 
cohort of all 
offspring born 
in Finland 
1987-2005. 
C-reactive 
protein levels 
from maternal 
serum 
specimens 
were assessed 
using a latex 
immunoassay 
and 
categorized in 
quintiles. The 
analyses were 
adjusted for 
gestational age 
of the blood 
draw, number 
of previous 
births and 
maternal 
lifetime history 
of depression. 
Childhood 
autism 
diagnoses 
were based 
on ICD-10 
(code F84.0). 
Increasing maternal 
C-reactive protein 
levels were 
significantly 
associated with 
autism in the 
offspring when 
comparing the risk 
of the highest and 
lowest quintiles (OR 
1.43, 95% CI 1.02-
2.01). 
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Animal studies 
 
Animal models have also been used to determine the possible 
mechanisms by which prenatal exposure to maternal infections and 
immune response increase the risk of autism spectrum disorders in the 
offspring. One study (82) chose the three core symptoms of autism for a 
closer investigation: social interaction and language deficits and 
repetitive/stereotyped behaviors. These were modeled in mice by 
different tests: ultrasonic vocalization analyses in pups’ isolation test and 
in response to female and male stimuli in adult male mice, the three 
chamber social test, scent marking test, marble burying test, self-
grooming test and olfactory sensitivity test. The offspring of mice injected 
with poly (I:C) at gestational day 10.5 showed autism-related changes in 
all the previously mentioned tests suggesting a role of exposure to 
prenatal maternal infections in increasing the offspring’s risk for autism 
spectrum disorders. 
 
The object of another animal study (83) was to determine the autism-
related immunological, molecular and behavioral effects of maternal 
immune activation exposure in the offspring. A rat model was used, 
injecting pregnant rats at gestational day 15 with lipopolysaccharide and 
collecting maternal serum, amniotic fluid and fetal brain for investigation. 
Also behavioral tests were conducted, to determine social preference, 
exploration and olfaction. A three-chamber test was used to model social 
preference, measuring the ratio of time the rat spent in the social and 
home boxes. Exploration was determined by measuring the number of 
nose-hole pokes and total movement in a box with 16 holes. Olfaction 
was assessed by measuring the time that the rats needed to find a 
buried cookie. After maternal lipopolysaccharide exposure, the results 
showed elevated pro-inflammatory cytokine levels in maternal serum, 
amniotic fluid and fetal brain at 4h, and the levels decreased but 
remained elevated at 24h. In the behavioral tests, decreased social 
preference and exploration behaviors were detected in offspring as 
juveniles and young adults. Additionally, dysregulation of 3285 genes 
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was observed, with increased expression of cell death and cellular stress 
genes and decreased expression of developmentally-regulated and 
brain-specific genes, similarly to previously observed expression 
changes in autism. The authors concluded that maternal immune 
activation induces a maternal cytokine response and selectively targets 
the fetal expression of neuronal migration and hypoxia-inducing genes. 
 
  
3.3 Other Mental Disorders 
 
In the recent years, also other mental disorders have been investigated 
with regard to prenatal exposure to maternal infection and immune 
response. The number of studies is still small, and they are reviewed 
below. 
 
3.3.1 Attention-Deficit Hyperactivity Disorder (ADHD) 
 
The relationship between exposure to prenatal maternal infection and 
risk of attention-deficit hyperactivity disorder (ADHD) has been examined 
in one study (84). The researchers focused on maternal genitourinary 
infection and pre-eclampsia as exposures potentially affecting the 
offspring’s ADHD risk. Exposure data were based on diagnoses made 
during pregnancy. An increased risk for ADHD was detected after both 
maternal genitourinary infection and pre-eclampsia exposure (OR 1.29, 
95% CI 1.23-1.35 and OR 1.19, 95% CI 1.07-1.32, respectively). 
Additionally, 53% (OR 1.53, 95% CI 1.32-1.77) increase in ADHD risk 
was found among children with both exposures compared to those 
without either of them. The sex and race of the child, birth weight, 
maternal age, education, alcohol and tobacco use were adjusted for in 
the analyses. 
 
3.3.2 Anorexia Nervosa  
 
To date, only one study (85) has investigated the exposure to prenatal 
maternal infection and anorexia nervosa risk in offspring. Exposure to 
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chickenpox, influenza, measles and rubella infections in the 
neurodevelopmentally most crucial, third to sixth months of pregnancy, 
were investigated. Researchers used an ecological study design, 
collecting data on numbers of monthly cases of each infection and the 
total living population in every year included in the study from national 
registries. To obtain the incidence rates, numbers of monthly infection 
cases were divided for the total living population in that year. 
 
The results showed an increased risk for anorexia nervosa in subjects 
exposed to peaks of chickenpox (OR 1.6, 95% CI 1.2-2.0) and rubella 
(OR 1.5, 95% CI 1.1-2.0) infections during the sixth month of pregnancy, 
which is later than what has been seen in studies concentrating on 
schizophrenia. The authors suggested that this could underlie the 
characteristic of anorexia nervosa patients that, unlike schizophrenic 
patients, they usually have normal intelligence quotient levels, as 
infection-associated events early in fetal life have been observed to have 
a stronger impact on neurodevelopment compared with infections later in 
fetal life. Additionally, exposure to the peak of chickenpox was 
associated with a lower age of onset of AN (17.0 ± 3.3 vs 18.5 ± years, p 
< 0.001). No association was found between prenatal measles or 
influenza exposure and anorexia nervosa risk (OR 1.0, 95% CI 0.7-1.3 
and OR 1.0, 95% CI 0.7-1.4, respectively).   
 
 
3.3.3 Bipolar Disorder  
 
Parboosing et al. 2013 (86) studied the relationship between prenatal 
exposure to maternal influenza and offspring’s risk for bipolar disorder. 
Exposure data was obtained from maternal medical records. They found 
a significantly increased bipolar disorder risk (OR 3.82, 95% CI 1.58-
9.24) in offspring exposed to maternal influenza at any time during 
pregnancy. If replicated in future studies, this finding might provide 
important information for prevention of the disorder. 
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3.3.4 Depression 
 
One study (87) has been published examining the potential effect of 
prenatal exposure to maternal viral infections on risk for depression in 
the offspring. Two large cohorts were compared, one known to have 
been exposed to prenatal maternal infection, the other not known to have 
exposed (N= over 3000 in both cohorts). The data on depression among 
the offspring were obtained by sending morbidity questionnaires to the 
primary care physicians of the subjects. The results showed no 
association (RR 1.0, 95% CI 0.8-1.2) between in-utero viral exposure 
and depression risk. Furthermore, the authors concluded that given the 
even distribution of effects around the unity with an overall RR of one, 
their study provided no evidence for an association with any antenatal 
virus exposure.   
 
Other mental disorders 
Reference Objective Sample Method Diagnosis/sy
mptomatology 
Key findings 
Pang et al. 
2009 
To examine 
whether in-utero 
viral infections 
result increased 
risk of depression 
later in life. 
N=3076 
participants 
born 1946-
1980 whose 
mothers 
suffered known 
viral infections 
in pregnancy 
and N=3076 
non-exposed 
controls.  
 Morbidity 
questionnaire
s were sent to 
the 
participants’ 
primary care 
physicians 
including 
several items 
all coded 
according to 
the IDC-9. 
No overall 
association between 
in-utero viral 
exposure and risk of 
depression was 
found. 
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Favaro et al. 
2011 
To examine the 
role of prenatal 
viral infections in 
the development 
of anorexia 
nervosa. 
All female 
individuals born 
in the Veneto 
region 1970-
1984 residing 
in the urban 
and suburban 
area of Padua 
(N=27 682). 
The monthly 
viral exposure 
data were 
obtained from 
the Italian 
Statistical 
Annals of 
Demographics 
and Public 
Health. Logistic 
regression 
analyses were 
used, adjusting 
for 
socioeconomic 
status, 
population 
density and 
month of birth. 
The anorexia 
nervosa 
diagnoses 
were obtained 
by consulting 
three 
registries: 
Register of 
the Eating 
Disorders 
Unit of the 
area, the 
Public Mental 
Health 
Database and 
the Register 
of Hospital 
Admissions. 
DSM-IV 
criteria were 
used, waiving 
the single 
criterion of 
amenorrhea 
for three 
consecutive 
months. 
Exposures to the 
peaks of chickenpox 
and rubella 
infections (OR 1.6, 
95% CI 1.2–2.0 and 
OR 1.5, 95% CI 
1.1–2.0) during the 
sixth month of 
pregnancy were 
significantly 
associated with an 
increased risk of 
anorexia nervosa. 
Mann et al. 
2011 
To examine the 
relationship 
between maternal 
genitourinary 
infection or pre-
eclampsia and risk 
of ADHD. 
N=84 721 
children born 
1996-2002 
from Medicaid 
billing data for 
pregnant 
women. 
Maternal 
genitourinary 
infections and 
pre-eclampsia 
were identified 
on the basis of 
diagnoses 
made during 
pregnancy 
coded by ICD-
9. Multivariable 
logistic 
regression 
model was 
used for data 
analysis, 
adjusting for 
sex, race, 
maternal 
education, 
maternal age, 
birth weight, 
alcohol use 
and tobacco 
use. 
ADHD 
diagnoses 
were obtained 
from the 
children’s 
Medicaid 
files, based 
on ICD-9 
(codes 
314.00, 
314.01). 
Maternal 
genitourinary 
infection and pre-
eclampsia were 
both associated with 
increased risk of 
ADHD (OR 1.29, 
95% CI 1.23-1.35 
and OR 1.19, 95% 
CI 1.07-1.32, 
respectively), and 
children with both 
exposures were 
53% more likely to 
have ADHD 
compared to 
children with neither 
exposure. 
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Parboosing 
et al 2013 
To examine 
whether maternal 
influenza during 
pregnancy is 
associated with 
bipolar disorder in 
the offspring. 
N=92 
individuals with 
bipolar disorder 
and N=722 
controls from 
Child Health 
and 
Development 
Study born 
1959-1966. 
Data on 
exposure to 
influenza was 
obtained from 
maternal 
medical 
records using 
ICD-9. 
Conditional 
logistic 
regression 
models were 
used for data 
analysis, 
adjusting for 
maternal age, 
race, 
education, and 
psychiatric 
history and 
gestational age 
at birth. 
BD diagnoses 
were made by 
using 
Structured 
Clinical 
Interview for 
DSM-IV. 
A significant, nearly 
fourfold (OR 3.82, 
95% CI 1.58-9.24) 
increase in the risk 
of bipolar disorder 
after exposure to 
maternal influenza 
infection at any time 
during pregnancy 
was found. 
 
 
3.3.5 Developmental Delay 
 
The same study mentioned above when discussing autism spectrum 
disorders (79), also explored the relationship between prenatal exposure 
to maternal influenza and fever and developmental delay risk in offspring. 
The exposure data were obtained by telephone interviews. As was the 
case for autism spectrum disorders, no association between maternal 
influenza exposure and offspring’s risk for developmental delay was 
found (OR 1.15, 95% CI 0.54-2.47). However, maternal fever was 
associated with an increased risk for developmental delay in the offspring 
(OR 2.50, 95% CI 1.20-5.20), suggesting that different infectious 
pathogens may act indirectly, via the teratogenic effect on developing 
nervous system of the fever they cause, in elevating the offspring’s risk 
for developmental delay.  
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3.4 Other Neurocognitive Deficits 
 
In addition to mental disorders, neurocognitive deficits have also been 
studied with regard to prenatal exposure to maternal infection and 
immune response. These studies are reviewed here. 
 
In one study (88), the potential association between in-utero exposure to 
acute inflammation and long-term major neurodevelopmental disability at 
age of 6 years was determined among offspring who were born preterm. 
Data on inflammation exposure were collected by trained research 
nurses. Major neurodevelopmental disability was defined as one or more 
of the following: IQ <70, cerebral palsy (CP), blindness, deafness, or 
other severe neurological motor deficit. Several psychometric measures 
were used to assess IQ of the children. In this study, no association was 
found between in-utero inflammation exposure and major 
neurodevelopmental disability.  
 
To examine the possible effect of prenatal exposure to maternal 
influenza on adulthood intelligence in the offspring, another research 
group (89) conducted intelligence tests among boys born in Norway 
between 1967 and 1973. While the mean intelligence score tends to 
increase from  one birth year to another, an inverse association was 
found with birth year 1970, when an influenza pandemic named as the 
Hong Kong flu haunted Europe. Thereby, men born 6 to 9 months after 
the epidemic had lower intelligence scores compared to the men born in 
the same months a few years before or after. 
 
Cytomegalovirus (CMV) infection -associated sequelae (deafness, 
hearing loss, auditory damage, neurodevelopmental delay) after 
serologically documented prenatal exposure to maternal CMV infection 
in pregnancies with and without abnormal findings on ultrasound 
examination and MRI have also been investigated (90). Significantly 
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more sequelae were observed in first-trimester than second-trimester 
exposed offspring (19.7% vs. 5.6%, P = 0.01). Additionally, abnormal 
findings on prenatal ultrasound examination were associated with an 
increased risk of sequelae, whereas abnormal MRI findings were not. 
Having both normal ultrasound and MRI findings decreased the sequelae 
risk in first- and second-trimester exposed infants to 15.6% and 2.0%, 
respectively. 
 
A few animal studies have also been conducted on neurocognitive 
deficits. The effect of lipopolysaccharide challenge in pregnant rats at 
gestational days 8, 10 and 12 on the offspring’s spatial learning and 
memory performances at different stages of life have been observed 
(91). The structure of hippocampal CA1 region and the expression of 
synaptophysin and glial fibrillary acidic protein were also determined in 
the offspring. The spatial learning and memory abilities were significantly 
reduced in the offspring of lipopolysaccharide exposed rats, and a 
significant neuron loss, decreased expression of synaptophysin and 
increased expression of glial fibrillary acidic protein in the hippocampal 
CA1 region were found. All findings except the increased expression of 
glial fibrillary acidic protein, which was seen in all three age stages, were 
more significant with age increasing. The authors suggested that this 
might reflect the effect of prenatal maternal inflammation in making 
spatial learning and memory abilities more sensitive to the age 
increasing.   
 
To examine the anxiety and stress responses and neurophysiological 
changes following prenatal lipopolysaccharide exposure, a rat model was 
used (92). Pregnant rats were injected with lipopolysaccharide at 
gestational day 10.5, and several tests assessing anxiety and stress 
responses, together with brain dopamine and serotonin (5-HT) 
determination, were conducted in the offspring. The results showed more 
anxiety-like behaviors and heightened stress response in 
lipopolysaccharide exposed rats, as well as reduction of the dopamine 
levels in the nucleus accumbens and serotonin levels the medial 
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prefrontal cortex and hippocampus. Additionally, glucocorticoid receptors 
in the dorsal hippocampus and the 5-HT1A- receptors in the dorsal and 
ventral hippocampus were reduced in the exposed offspring. These 
molecular level findings may be associated with the observed increases 
in stress-response and anxiety like behaviors of the offspring. 
 
 
Other Neurocognitive Deficits 
Reference Objective Sample Method Diagnosis/sy
mptomatology 
Key findings 
Andrews et 
al. 2008 
To determine the 
association 
between in utero 
exposures to 
acute inflammation 
and long-term 
major 
neurodevelopment
al disability at age 
of six years among 
children born prior 
to the 32nd 
gestation week. 
A cohort of 
N=424 
consecutive 
single 
pregnancies 
delivered 
between 23 
and <32 
weeks.  
Pregnancy and 
neonatal data 
were collected 
by trained 
research 
nurses. 
Analyses were 
adjusted for 
gestational age 
and ethnicity. 
To assess 
intelligence 
quotient (IQ), 
a wide range 
of 
psychometric 
measures 
including the 
Wechsler 
Intelligence 
Scale for 
Children-IV or 
the 
Differential 
Ability Scales, 
was used. 
Major 
neurodevelop
mental 
disability was 
defined using 
a composite 
that included 
one or more 
of the 
following: IQ 
<70, CP, 
blindness, 
deafness, or 
other severe 
neurological 
motor deficit 
such as 
abnormal 
balance, 
impaired 
coordination, 
dystonia, or a 
seizure 
disorder that 
affected 
function. 
Delivery gestational 
age, neonatal 
complications and 
caregiver IQ were 
significantly 
associated with 
increased risk of 
severe 
neurodevelopment 
outcomes, whereas 
in utero exposure to 
acute inflammation 
was not. 
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Eriksen et al. 
2009 
To examine the 
hypothesis that 
prenatal exposure 
to an influenza 
pandemic was 
associated with 
reduced 
intelligence in 
adulthood. 
All boys born 
alive in single 
birth 37-43 
weeks’ 
gestation in 
Norway 1967-
1973 (N=205 
634). 
Statistical 
analyses were 
adjusted for the 
continuous 
birth year 
variable, birth 
order, being 
born small for 
gestational 
age, maternal 
age, maternal 
education, 
marital status, 
paternal age 
and paternal 
education.  
The 
intelligence 
test data were 
obtained by 
conducting 
three 
subtests: 
1) the 
Arithmetic 
Test; 2) the 
Word 
Similarities 
Test; and 3) 
the Figures 
Test. 
An inverse 
association between 
the birth months 
July, August, 
September and 
October in 1970 and 
intelligence score 
was found. Thus, 
the intelligence 
scores of the men 
born six to nine 
months after the 
epidemic were lower 
than the mean 
values for the men 
born in the same 
months a few years 
before or after. 
Lipitz et al 
2013 
To determine the 
outcome of 
pregnancies with 
documented 
cytomegalovirus 
(CMV) infection 
with and without 
abnormal findings 
on ultrasound 
examination and 
MRI.  
N=71 first-
trimester and 
N=74 second-
trimester CMV-
infected 
individuals in 
Israel. 
CMV infection 
data was 
obtained from 
serial 
screening.  
Patients 
underwent 
serial prenatal 
ultrasound 
scans and 
fetal MRI. All 
neonates 
underwent 
ocular fundus 
examination, 
ultrasound 
brain scan 
and hearing 
evaluation, 
and were 
followed by a 
pediatrician. 
Patients with first-
trimester CMV 
infection had infants 
with significantly 
more sequelae 
(auditory damage or 
neurodevelopmental 
disabilities) than 
second-trimester 
infected patients 
(19.7% vs. 5.6%). 
Abnormal prenatal 
ultrasound findings 
were associated 
with increased risk 
of sequelae, and 
having both normal 
MRI and ultrasound 
findings decreased 
the risk associated 
with infections (to 
15.6% and 2.0%, 
respectively).  
 
 
 
4 Discussion 
 
According to the accumulating data from the human studies in the field, 
there seems to be an association between prenatal exposure to maternal 
influenza and risk for schizophrenia spectrum disorders and schizotypy in 
the offspring, as this finding has been replicated in several studies (15-
17, 21, 23, 31). However, also negative findings exist (18-20). For the 
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other maternal infections having been studied, replications exist for HSV-
2 (93-94) and toxoplasma gondii (95-96). Researchers have tried to 
elucidate the underlying mechanisms by which the infections increase 
the risk of offspring’s schizophrenia-related structural and behavioral 
abnormalities in animal studies, but the variation in the investigated 
mechanisms and structures has not lead to replications for any specific 
mechanism. For autism spectrum disorders, replications in human 
studies exist for the relationship between prenatal exposure to maternal 
febrile episodes (79,80) as well as cytokines IL-4 and IL-5 in amniotic 
fluid (97-98), and elevated autism risk in the offspring. Of other mental 
disorders, there are no replicated findings.  
 
It seems likely that the timing of the prenatal exposure has an effect on 
the outcome, resulting in different disorders according to the time of 
maternal infection during the pregnancy. As an example, exposure to 
maternal infection during early to mid-pregnancy has been related to 
elevated risk of schizophrenia, whereas exposure during the sixth month 
of pregnancy seems to be associated with an increased risk for anorexia 
nervosa. This might be due to the different effects in different times on 
neurodevelopment in the pathogenesis of these two disorders. 
 
For schizophrenia spectrum disorders and influenza, the existing data is 
not fully consistent, as both positive and negative findings exist. 
However, it is possible that some negative findings reflect power issues 
rather than a true lack of association. To overcome this problem, it would 
be important to use large data sets. Additionally, different studies have 
used slightly different outcomes (schizophrenia, schizophrenia spectrum 
disorders, schizotypy), which may have affected the results. As many of 
the reviewed studies relied on epidemiological exposure data, it is 
impossible to determine the number of mothers actually infected and the 
exact timing of the exposure. This aspect is reflected in the different 
timings of the infection between epidemiological and serologic studies: 
as the epidemiological studies show that second trimester exposure 
would be the most critical, Brown et al. 2004 (31) found in their serologic 
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study that first-trimester influenza exposure significantly elevated the risk 
of schizophrenia spectrum disorders. This might be due the earlier 
infection diagnosis when assaying the serum samples.  
 
Because of the smaller number of studies investigating the effect of 
prenatal exposure to maternal infections on the offspring’s risk for autism 
spectrum disorders, replications of findings are more rare. Maternal fever 
and elevated levels of IL-4 and IL-5 in the amniotic fluid have been found 
to be related with an elevated risk, suggesting an indirect mechanism by 
which the infections might increase the risk for autism spectrum 
disorders, i.e. the infectious agent itself does not cause the elevation in 
the risk for autism spectrum disorders but the teratogenic effect of 
hyperthermia or cytokines might underlie the elevation. However, in the 
case of maternal fever, the studies with positive findings relied on 
telephone interviews in collecting the exposure data, which may have 
affected the results, as the mothers of children with autism spectrum 
disorders may have remembered better whether they had had fever 
during pregnancy (recall bias).   
 
In most of the reviewed studies, one common caveat is the lack of 
controlling for the genetic liability to the disorder. As it is significant in 
many mental disorders, this may have affected the results in a way that 
the increased risk may not be due to the infectious exposure alone but 
the synergism between both of the factors. The synergism hypothesis 
was tested by Clarke et al. (27), and they found that risk for 
schizophrenia after prenatal exposure to pyelonephritis was five times 
greater in the individuals having a family history of psychosis compared 
to those who did not. There are also some studies (25, 28, 34) adjusting 
the analyses for parental history of psychiatric disorder. This increases 
the independency of the findings of an effect of infections, because 
psychiatric disorders have been found to be associated with increased 
number of infections (99). Also, not all the studies have adjusted for 
potential confounding factors (e.g. maternal age, education, urbanicity), 
which should be taken into account when looking at the results. 
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Considering the findings from the reviewed studies, it seems that the 
mechanism underlying the elevation of risk for different mental disorders 
after prenatal exposure to maternal infections may act trough an indirect 
and common pathway for different infections. Rather than specific 
infectious agents, some factors acting in the immune response and 
inflammation (cytokines or acute phase proteins, for example) common 
to various infections might be the critical key factors behind the findings. 
Intriguing findings already exist, as elevated maternal levels of IL-8 and 
CRP have been found to be associated with an increased risk for 
schizophrenia spectrum disorders (30, 34). Similar findings of an 
association between CRP and childhood autism also exist (81). 
However, replications of these two findings are needed and, as 
discussed above, the genetic liability and potential confounding factors 
should be taken into account. In addition to schizophrenia and autism, 
other mental disorders would also need more investigation in terms of 
prenatal exposure to maternal infections and risk for these disorders.  
 
In conclusion, there seems to be an association between prenatal 
exposure to maternal infections and immune response and the 
offspring’s risk for different mental disorders. To yield stronger evidence 
for these findings, future studies should ideally use larger study samples 
with prospectively collected maternal serum samples and genetically 
sensitive study designs (e.g. sibling design, twin design, novel designs 
with genetically unrelated offspring), as well as adjust for various 
potential confounding factors.  
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Supplementary table 1. 
Summary of the included animal studies covering possible mechanisms underlying the effect of prenatal 
exposure to infection or maternal immune response on the offerings risk for mental disorders. 
CMV, Cytomegalovirus; DA, Dopamine; DHEA, Dehydroepiandrosterone; GABA, Gamma-Aminobutyric 
Acid; GFAP, Glial Fibrillary Acidic Protein; IL-1β, Interleukin 1β; IL-2 Interleukin 2; IL-4 Interleukin 4; IL-6, 
Interleukin 6; INF-γ, Interferon γ; LPS, Lipopolysaccharide; SYP, Synaptophysin; TNF-α, Tumor Necrosis 
Factor α; 5-HT, Hydroxytryptamine,  
ASR, Acoustic Startle Response; MIA, Maternal Immune Activation; PPI, Prepulse Inhibition; USV, 
Ultrasonic vocalizations 
Reference Objective Method Key findings 
Schizophrenia Spectrum Disorders (SSDs) 
Fatemi et al. 1999 To examine whether 
human influenza 
infection in pregnant 
mice would alter the 
expression of reelin in 
neonatal brains. 
Pregnant mice were 
infected with human 
influenza virus in the 
ninth day of pregnancy. 
The brains of the 
offspring were then 
investigated in postnatal 
day zero. 
Prenatally-infected 
brains showed significant 
reductions in reelin-
positive cell counts in 
layer I of neocortex and 
other cortical and 
hippocampal layers 
when compared to 
controls. Moreover, viral 
infection caused 
decreases in neocortical 
and hippocampal 
thickness. 
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Gilmore et al. 2004 To study the effect of 
infection-related 
cytokines on the 
dendritic development of 
cortical neurons. 
Primary mixed neuronal 
cultures from embryonic 
day 18 rats were 
obtained and exposed to 
0, 100 or 1000 units 
(U)/ml of IL-1β, TNF-α, 
IL-6 or IL-1β + TNF-α for 
44 h. Number of primary 
dendrites, nodes and 
total dendrite length was 
determined. 
100 U of TNF-α 
significantly reduced the 
number of nodes (27%) 
and total dendritic length 
(14%), and 100 U of IL-
1β + TNF-α significantly 
reduced the number of 
primary dendrites (17%), 
nodes (32%) and total 
dendritic length (30%), 
but these did not affect 
the overall neuron 
survival. At 1000 U, each 
cytokine significantly 
reduced the number of 
primary dendrites (14-
24%), nodes (28-37%), 
total dendritic length (25-
30%) and neuron 
survival was reduced 
(14-21%). These findings 
are consistent with the 
neuropathology of 
schizophrenia. 
Ashdown et al. 2006 To elucidate the site of 
action of LPS in 
increasing the risk of 
schizophrenia. 
Pregnant rats received 
i.p. 5 Ci of iodinated LPS 
at gestational day 18, 
and its distribution was 
assessed in 
maternal/fetal tissues. 
Additionally, induction of 
the inflammatory 
cytokines IL-1β, IL-6 and 
TNF-α was measured in 
maternal/fetal tissues 
after LPS challenge. 
LPS was detected in 
maternal tissues and 
placenta, but not the 
fetus. Significant 
increases in IL-1β, IL-6 
and TNF-α were 
detected in maternal 
plasma and placenta, but 
not in fetal liver or brain. 
A significant increase in 
IL-1β was detected in 
fetal plasma. These 
findings suggest indirect 
actions of LPS in 
increasing the risk of 
schizophrenia. 
Ozawa et al. 2006 To examine whether 
maternal immune 
response to viruses 
influenced fetal brain 
development leading to 
schizophrenia. 
Poly (I:C) was 
administered into 
pregnant mice. 
Behavioral evaluations, 
sensorimotor gating and 
biochemical evaluation of 
the dopaminergic 
function in the offspring 
of saline- or poly (I:C) -
treated dams were 
conducted. 
In juveniles, no 
difference was found 
between the two groups. 
In adults, poly (I:C) 
administration caused 
increased subcortical DA 
function and cognitive 
impairment. 
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Makinodan et al. 2008 To examine the 
relationship between 
maternal infection and 
schizophrenia in the 
offspring by examining 
the infection’s effect on 
previously found 
abnormalities in human 
brains of individuals with 
schizophrenia. 
Poly (I:C) or saline was 
injected into pregnant 
mice at embryonic day 
9.5. The brains of their 
offspring were examined 
for biochemical end 
histological abnormalities 
with special reference to 
oligodendrocytes. 
A significant decrease of 
myelin basic protein 
mRNA and protein was 
detected at early 
postnatal periods in poly 
(I:C) mice. The 
hippocampus of juvenile 
poly (I:C) mice was less 
myelinated and axonal 
diameters were 
significantly smaller than 
in control mice, but there 
was no significant loss of 
oligodendrocytes. These 
abnormalities reverted to 
normal levels at the adult 
stage. 
Vuillermot et al. 2010 To examine the 
hypothesis that prenatal 
immune challenge has 
an impact on structural 
and functional 
dopaminergic 
development. 
Pregnant mice were 
injected with either poly 
(I:C) or vehicle at 
gestational day nine. The 
dopaminergic structural 
and functional 
development was then 
evaluated from fetal to 
adult stages of life in the 
offspring. 
The prenatal immune 
challenge led to 
dopaminergic 
maldevelopment starting 
in the fetal stages of life 
and dependent on 
postnatal maturational 
processes.  
Ducharme et al. 2012 To examine the effects of 
prenatal infection on the 
GABAergic 
neurotransmission in the 
brain of the offspring, 
which has been found to 
be impaired in patients 
with schizophrenia. 
At gestational day nine, 
mice received a tail vein 
injection of either poly 
(I:C) or saline. The 
brains of the offspring 
were investigated by 
immunohistochemistry. 
Prenatal infection 
reduced the density of 
parvalbumin- but not 
somatostatin-positive 
interneurons in the CA1 
area of the hippocampus 
and strongly reduced the 
strength of inhibition 
early during postnatal 
development. 
Additionally, reduced 
theta oscillation 
generated in the CA1 
area was found. 
Maayan et al. 2012 To examine the effect of 
poly (I:C) treatment on 
schizophrenia-like 
behavioral, 
neurochemical and 
neuorophysiological 
abnormalities in rodent 
offspring. 
Pregnant rats at 
gestational day 15 were 
injected with either poly 
(I:C) or saline. In both 
groups, there were rats 
with and without 
pretreatment with DHEA. 
Acoustic startle response 
test, prepulse inhibition 
test and corticosterone 
level tests were used to 
evaluate the possible 
schizophrenia-related 
changes caused by poly 
(I:C) treatment. 
Poly (I:C) prenatal 
administration was 
associated with 
alterations in the 
ASR/PPI and the HPA-
axis stress response in 
rat offspring on postnatal 
day 90. We show that 
pretreatment with DHEA 
reverses poly (I:C)- 
related ASR/PPI 
disruption in female rats 
and normalizes HPA-axis 
stress response in a 
united group of male and 
female rats. 
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Pacheco-Lopez et al. 
2013 
To test the hypothesis 
that metabolic alterations 
pertinent to SSDs can be 
primed by an 
environmental risk factor 
associated with the 
disorder, namely 
prenatal exposure to 
immune challenge. 
Pregnant mice on 
gestational day nine 
received either a single 
injection of poly (I:C) or 
vehicle. Metabolic effects 
in the offspring were 
studied using high-
resolution computed 
tomography and fully 
automated indirect 
calorimetry system, 
along with an oral 
glucose tolerance test 
and plasma cytokine and 
corticosterone 
measurements. 
Prenatal immune 
activation caused altered 
glycemic regulation and 
abnormal ingestive 
behavior in 
periadolescence and led 
to an adult onset of 
excess visceral and 
subcutaneous fat 
deposition. These effects 
were accompanied by 
age-dependent changes 
in peripheral secretion of 
proinflammatory IL-6 and 
TNF-α and T cell–related 
IL-2 and IFN- γ cytokines 
and by increased release 
of the stress hormone 
corticosterone in 
periadolescence. 
Scizophrenia and Autism 
Garbett et al. 2012 To examine the 
immediate effects of MIA 
induced by influenza 
virus, poly (I:C) and IL-6 
on the fetal brain 
transcriptome to 
determine the 
mechanisms by which 
maternal infection 
increases the risk for 
schizophrenia and 
autism in the offspring. 
MIA was induced in 
pregnant mice by 
influenza virus, poly (I:C) 
and IL-6 at embryonic 
day 9.5. The 
transcriptomes from the 
embryonic brains were 
investigated. 
All three MIA treatments 
lead to strong and 
common gene 
expression changes in 
the embryonic brain. 
Most notably, there is an 
acute and transient 
upregulation of the α, β 
and γ crystallin gene 
family. Furthermore, 
levels of crystallin gene 
expression are 
correlated with the 
severity of MIA as 
assessed by placental 
weight. 
52 
 
Baharnoori et al. 2012 To investigate the 
potential effects of 
prenatal immune 
activation on early 
neurophenotypic 
presentations using a set 
of behavioral test battery. 
Pregnant rats were 
administered with 100 
µg/kg LPS i.p. at 
gestational days 15 and 
16. Behavioral test 
battery was used to 
investigate the 
neurophenotypic 
presentations. The 
offspring’s brains were 
investigated by 
quantitative real-time 
polymerase chain 
reaction. 
No significant effect on 
maternal behavior or 
mother-pup interaction 
by this treatment during 
the first postnatal week. 
No major changes in 
physical developmental 
milestones of pups were 
noted from postnatal 
days six to sixteen. 
Importantly, prenatal 
LPS-exposed pups had a 
significant decrease in 
the number and duration 
of ultrasonic vocalization 
calls at 3rd and 5th 
postnatal days. Prenatal 
LPS treatment also led to 
impairments in nest-
seeking behavior and 
odor-stroke associative 
learning in neonatal rats 
at 8th and 9th postnatal 
days. At the molecular 
level, significant 
decrease in the 
expression of cortical 
5HT1A and 5HT1B 
messenger RNA at 3rd 
postnatal day was 
detected. These findings 
suggest a role of 
prenatal exposure to an 
immune activator in 
impairing the 
social/communicative 
behavior reported in 
individuals with autism 
and schizophrenia. 
Autism Spectrum Disorders (ASD) 
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Malkova et al. 2012 To examine the effect of 
MIA on three core 
symptoms of autism in 
the offspring. 
Pregnant mice were 
injected with either poly 
(I:C) or saline at day 10.5 
of pregnancy. Pups’ 
USVs in the isolation 
test, adult male USV 
responses to female and 
male stimuli and USV 
analysis were conducted, 
along with the three 
chamber social-, scent 
marking-, marble 
burying-, self-grooming- 
and olfactory sensitivity 
tests. These were used 
as mouse models of the 
three core symptoms of 
autism: social interaction 
and language deficits, 
and 
repetitive/stereotyped 
behaviors. 
Compared to pups born 
to saline-injected 
mothers, pups born to 
MIA mothers produce a 
lower rate of USVs in the 
isolation test starting at 
day eight. The quality of 
the vocalizations is also 
different; analysis of 
sound spectrograms of 
ten day-old pups shows 
that male pups from MIA 
mothers emit significantly 
fewer harmonic and 
more complex and short 
syllables. These 
communication 
differences are also 
apparent in adult 
offspring. Compared to 
controls, adult MIA males 
emit significantly fewer 
USVs in response to 
social encounters with 
females or males, and 
display reduced scent 
marking in response to 
female urine. Regarding 
a second autism 
symptom, MIA males 
display decreased 
sociability. In a third test 
of characteristic autism 
behaviors, MIA offspring 
exhibit increased 
repetitive/stereotyped 
behavior in both marble 
burying and self-
grooming tests. 
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Oskvig et al. 2012 To investigate the 
immunological, 
molecular, and 
behavioral effects of MIA 
in the offspring. 
Pregnant rats were given 
an i.p. injection of LPS or 
saline on gestational day 
15. Maternal serum, 
amniotic fluid, and fetal 
brain were collected for 
investigation and chip-
based immunoaffinity 
capillary electrophoresis 
with laser-induced 
fluorescence detection 
was used for analysis. 
Microarray, quantitative 
real-time polymerase 
chain reaction and 
behavioral tests were 
also conducted. 
LPS significantly 
elevated pro-
inflammatory cytokine 
levels in maternal serum, 
amniotic fluid, and fetal 
brain at 4 h, and levels 
decreased but remained 
elevated at 24 h. 
Offspring born to LPS- 
treated dams exhibited 
reduced social 
preference and 
exploration behaviors as 
juveniles and young 
adults. In the microarray 
analysis, dysregulation of 
3,285 genes in restricted 
functional categories, 
with increased mRNA 
expression of cellular 
stress and cell death 
genes and reduced 
expression of 
developmentally-
regulated and brain-
specific genes, were 
observed. These results 
provide a novel 
mechanism by which 
MIA induces the 
widespread down-
regulation of critical 
neurodevelopmental 
genes, including those 
previously associated 
with autism. 
Other Neurocognitive Deficits 
Hao et al. 2010 To examine the effects of 
prenatal exposure to 
LPS repeatedly on 
spatial learning and 
memory performances in 
rat offspring’s lifetime. 
Sixteen pregnant rats 
were divided into two 
groups treated with 
either LPS or saline at 
gestational days eight, 
ten and twelve. After 
delivery, the rat 
offspring’s spatial 
learning and memory 
abilities were tested by 
Morris water maze at the 
age of three (young), ten 
(adult) and twenty (aged) 
months. The structure of 
hippocampal CA1 region 
was observed by light 
microscopy, and the 
expression of SYP and 
GFAP in CA1 region 
were measured by 
LPS offspring needed 
longer escape latency 
and path-length in the 
Morris water maze and 
presented a significant 
neuron loss, decreased 
expression of SYP and 
increased expression of 
GFAP in CA1 region. All 
these findings were more 
significant with age 
increasing. 
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immunochemistry. 
Lin et al. 2012 To examine the anxiety 
and stress responses 
and neurophysiological 
changes after prenatal 
exposure to LPS 
challenge. 
Pregnant mice were 
injected with either LPS 
or saline at embryonic 
day 10.5. The stress and 
anxiety-like responses in 
the offspring were 
evaluated by open field-, 
elevated plus maze-, 
novelty-induced 
hypophagia-, restraint 
stress-, dexamethasone 
challenge- and 
corticotrophin-releasing 
hormone challenge tests. 
Brain DA- and 5-HT 
biochemical studies were 
also conducted.  
LPS rats displayed more 
anxiety-like behaviors 
and heightened stress 
responses. DA in the 
nucleus accumbens and 
5-HT in the medial 
prefrontal cortex and the 
hippocampus were 
significantly reduced in 
LPS rats. Their 
glucocorticoid receptors 
in the dorsal 
hippocampus and the 5-
HT1A receptors in the 
dorsal and ventral 
hippocampus were also 
reduced. In addition, 
chronic but not acute 
fluoxetine treatment 
reversed the behavioral 
changes and increased 
hippocampal 5-HT1A 
receptor expression. 
These alterations may be 
associated with the 
increases in stress 
response and anxiety-
like behaviors in the 
offspring. 
 
 
 
 
